Die FDA het zanubrutinib goedgekeur vir die behandeling van Waldenstrom se makroglobulinemie

September 2021: Vir volwasse pasiënte met Waldenström se makroglobulinemie het die FDA zanubrutinib (Brukinsa, BeiGene) (WM) goedgekeur. In ASPEN (NCT03053440) is zanubrutinib vergelyk met ibrutinib in pasiënte met MYD88 L265P mutat.

Beta Thalassemie, BMT, Covid-19, Indië, talassemie

Beta Thalassemia en die oorweging daarvan met COVID-19

Julie 2021: Beta-talassemie is 'n oorerflike toestand wat veroorsaak word deur mutasies in 'n geen wat betrokke is by die produksie van 'n komponent van hemoglobien, die proteïen wat suurstof deur die liggaam vervoer. Hierdie mutasies verbied óf ..

Behandelingsopsies vir leukemie

Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine careful classification and prognosis stratification to formulate treatment p..

Navorsingsvordering in limfoom

On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in the event. At the meeting, the research on lymphoma was brilliant, not o..

MD Anderson kanker sentrum behandeling verhaal van 'n leukemie pasiënt

Eddle and Pearlie Saddler, as his wife Pearlie hopes, "enjoy a regular life" in their South Carolina town. When they rested, Saddlers volunteered and participated in the service in the church. "We go there often, especially Eddi..

PD-1-remmerimmunoterapie vir B-sel limfoom

'n Oorsig geskryf deur Young, MD, Anderson Cancer Center, VSA, het die toepassing van PD-1-remmer-immunoterapie in B-sel limfoom verduidelik. (Bloed. Aanlyn weergawe op 8 November 2017. doi: 10.1182 / bloed-2017-07-740993.)PD-1 immune..

Studie vind nuwe idees vir die behandeling van leukemie

A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production of fat cells in the bone marrow and adjusting the bone marrow microenvir..

Perifere T-sel limfoom het uitdagings

The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies greatly, and often lacks important phenotypic information to fully distingui..

Die middel wat deur AstraZeneca geteiken word, het 'n nuwe manier om chroniese limfositiese leukemie te behandel, Acalabrutinib

Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL).The researchers believe that BTK inhibitors comb..

Patogenese en behandeling van volwasse T-sel gewasse

Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently, "Nature" series of two articles published a new interpretation of the pathogene..